Astrana Health, Inc.
ASTH · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $49,932 | $57,849 | $45,741 | $46,055 |
| Dep. & Amort. | $27,927 | $17,748 | $17,543 | $17,517 |
| Deferred Tax | -$4,249 | -$12,444 | -$14,278 | $7,671 |
| Stock-Based Comp. | $34,536 | $22,040 | $16,101 | $6,745 |
| Change in WC | -$63,613 | -$23,388 | -$1,955 | -$33,638 |
| Other Non-Cash | $7,665 | $6,422 | $18,976 | $25,985 |
| Operating Cash Flow | $52,198 | $68,227 | $82,128 | $70,335 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$8,031 | -$28,529 | -$22,940 | -$19,223 |
| Net Acquisitions | -$156,135 | -$7,537 | -$18,457 | -$3,905 |
| Inv. Purchases | -$2,609 | -$6,151 | -$1,854 | -$28,000 |
| Inv. Sales/Matur. | $124 | $491 | $31,671 | $67,612 |
| Other Inv. Act. | -$25,744 | -$23,797 | $4,467 | $56 |
| Investing Cash Flow | -$192,395 | -$65,523 | -$7,113 | $16,540 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $152,705 | $79,171 | -$828 | -$58,692 |
| Stock Issued | $0 | $0 | $0 | $40,134 |
| Stock Repurch. | -$937 | -$10,192 | -$9,250 | -$5,739 |
| Dividends Paid | -$4,036 | -$62,074 | -$14,030 | -$31,089 |
| Other Fin. Act. | -$12,586 | -$3,484 | $4,023 | $7,638 |
| Financing Cash Flow | $135,146 | $3,421 | -$20,085 | -$47,748 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$5,051 | $6,125 | $54,930 | $39,127 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $294,152 | $288,027 | $233,097 | $193,970 |
| End Cash | $289,101 | $294,152 | $288,027 | $233,097 |
| Free Cash Flow | $44,167 | $39,698 | $59,188 | $51,112 |